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Introduction
Diabetes mellitus during pregnancy affects fetal 
development adversely and causes metabolic disorders in
neonates. The most important effect of diabetes on the fetus is
macrosomia. The fetus will increase its insulin levels in response
to the mother’s hyperglycemia  and this results in macrosomia
(1). Alteration in the growth hormone/insulin-like growth 
factor-1 axis is a risk factor for cardiovascular disease. Both
hypersecretion and hyposecretion of growth hormone are
known to increase the  risk for cardiovascular disease (2).
Abnormalities in lipoprotein composition and concentration are
also associated with macrosomia at birth and, elevated 
lipoprotein levels which persist after birth may play a role in the
development of atherosclerosis and diabetes in adult life (3).
Clinical complications of atherosclerosis in  adulthood have a
basis in childhood (4). Tracy et al (5) pointed to early 
atheromatous changes in the  aorta. With modern technology,
early vascular changes related to atherosclerosis can be imaged
from peripheral vessels by sonography (6).
In this study, we aimed to assess the risk of  subclinical 
atherosclerosis by measuring carotid artery intima-media 
thickness (CA-IMT) and left ventricular mass index (LVMI) in
infants of diabetic mothers (IDM) by B-mode ultrasonography.
Also, we investigated the relationship between CA-IMT and 
cardiovascular risk factors.
ABSTRACT
Objective: Infants of diabetic mothers (IDM) are considered as a risk 
group for atherosclerosis. Increased aortic intima-media thickness has been
reported in IDM. The purpose of this study was to assess carotid artery 
intima-media thickness (CA-IMT), left ventricular mass index (LVMI)  and 
atherosclerotic risk factors in IDM.   
Methods: Thirty IDM and 25 healthy controls were included in the study. Of
these infants, 14 were appropriate-for-gestational age (AGA) and 16 were
large-for-gestational age (LGA). CA-IMT and LVMI were obtained by M-mode
echocardiographic examination.  The relationship between parameters of 
atherosclerosis and echocardiographic measurements was assessed by
Pearson’s correlation analysis. 
Results: LVMI was higher in LGA IDM when compared to AGA IDM and
controls. CA-IMT was not significantly different between the groups and
was also not related to atherosclerotic risk factors. Serum lipid and
insulin levels were higher in LGA IDM when compared with AGA IDM 
and controls. There were no correlations between CA-IMT, LVMI and 
atherosclerotic risk factors.
Conclusions:In contrast to previous reports indicating an increase in CA-IMT
in IDM, no differences were found between IDM and controls in this study. 
Our results indicate that  macrosomic IDM are prone to hypertrophic 
cardiomyopathy but not to atherosclerotic changes in the blood vessels.    
K Ke ey y   w wo or rd ds s: : Intima-media thickness, left ventricular mass, macrosomic
newborns
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R Re ec ce ei iv ve ed d: : 16.02.2011 A Ac cc ce ep pt te ed d: : 26.05.2011Materials and Methods
This study was performed prospectively between
December 2005 and December 2007 at Selcuk University,
Meram School of Medicine, Pediatric Endocrinology
Department. The study was approved by the local ethics 
committee. Signed informed consent was obtained from the
parents.  
Thirty  IDM and 25 healthy controls were included in the
study. Fourteen of the IDM were appropriate-for-gestational
age (AGA) and sixteen were large-for-gestational age (LGA).
Gestational ages were determined by one or a combination of
information based on mother’s last menstrual date, obstetrical
ultrasound and Ballard score.
Infants of mothers with a history of cardiovascular disease,
high cholesterol level, hypertension, smoking, pre-eclampsia
were excluded. Also, infants of mothers who had a history of
taking drugs affecting lipid metabolism, such as steroids and
ritodrine, were excluded. Infants with asphyxia, prematurity,
respiratory distress, dysmorphic features, a stressful birth 
history and intrauterine infection were not included in the study.
Neonates whose birth weights were above the 90th
percentile for gestational age and sex according to Lubchenco
curves were accepted as macrosomic. IDM were divided into
two groups as LGA and AGA.
Weight was measured at birth by using digital scale and
recorded in grams. Length and head circumference were
measured using a standard board and tape and were recorded
in centimeters. The ponderal index (PI) was calculated by the
formula “weight (g) x 100/cm3.  A PI value over 2.85 was
accepted as an index of LGA.
Cord blood samples were taken from the study and 
control groups. Cord blood samples received from Rh negative
mother’s babies for blood group determination were used as
the control group. Plasma triglyceride, total cholesterol, 
high-density lipoprotein (HDL), low-density lipoprotein (LDL),
very low-density lipoprotein (VLDL) and glucose levels were
analyzed by colorimetric method (Beckman Coulter). 
Plasma insulin and C-peptide levels were determined by 
chemiluminescence method (Immulite 2000, BioDPC, USA).
Reference ranges accepted for insulin and C-peptide were 1.9-
23 mIU/mL and 0.9-7.1 ng/dL, respectively.
Ultrasound Examination 
Ultrasound assessment of all infants was performed by 
the same clinician who was uninformed about the patient’s 
laboratory values and risk factor levels. The subjects were 
laid quietly for 10 minutes before the first scan in a dark, 
temperature-controlled room. Scanning was performed in the
supine position while the head was slightly extended and
turned to the left. High-resolution B-mode ultrasonography of
the right common carotid artery was performed by using a
Philips Sonos 5500 Doppler  ultrasound with  3.5 MHz probe.
Longitudinal images of the common carotid artery were
obtained by combination of B-mode and color Doppler 
ultrasound examinations. The IMT of the far wall of the 
common carotid artery was measured with the electronic
calipers of the machines, as described by Pignoli et al (7). 
On a longitudinal two-dimensional ultrasound image of the
carotid artery, the posterior  wall of the carotid artery 
was shown as two echogenic lines. The external line was 
considered as the limit of medial adventitia and the inner 
line - as the limit of the luminal intima. The distance between
these two parallel lines shows the intimal medial thickness. 
CA-IMT was calculated by taking the mean value of three
measurements of maximum far wall thickness obtained from
the common carotid artery, 10 mm below the carotid bulb. 
Echocardiography
Echocardiographic examination was conducted in all 
infants in the postnatal 48-72 hours by the same clinician. Two-
dimensional guided M-mode echocardiography (Philips Sonos
5500) was performed to determine LVM. The ventricular 
septal (IVSd) and posterior wall thicknesses at end-diastole
(LVPWd), and the left ventricular end-diastolic (LVEDd) 
dimensions were determined according to the American
Society of Echocardiography recommendations (8). LVM was
calculated by using the Devereux formula (9): 
0.8 * (1.04 * [(LVEDd+ IVSd + LVPWd) ** 3 - (LVEDd) **
3)] + 0.6
We made a correction according to birth weight. LVMI was
obtained by dividing LVM by birth weight. In our study, we 
evaluated corrected LVM.
Statistics
All statistical analyses were performed using SPSS 13.0.
Descriptive data were shown as mean±SD. Compliance with
normal distribution was analyzed. Kruskal-Wallis variance
analysis was performed for data which did not conform to a
normal distribution. Bonferroni-corrected Mann-Whitney U
test was applied for dual comparisons. For the relationship
between CA-IMT and other parameters, Pearson’s 
correlation test was used.   A p-value lower than 0.05 was
considered statistically significant.
Results
The clinical characteristics and laboratory findings of the
IDM and control neonates are shown in Table 1. Mean birth
weight, length, and head circumference were significantly high
in LGA IDM  when compared to AGA IDM and controls. Among
laboratory findings, only insulin levels were significantly high in
the IDM groups.  LVMI also was higher in both AGA and LGA
groups of IDM as compared to the controls. No differences in
CA-IMT were noted among the groups.  
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cardiovascular risk factors and CA-IMT are shown in Table 2,
and the correlations between anthropometric measurements,
cardiovascular risk factors and  LVMI are shown in Table 3.
There were no significant correlations of anthropometric 
measurements, lipid profiles, glucose, insulin and C-peptide 
levels with either  LVMI or CA-IMT.
Discussion
Fetal macrosomia and obesity are common complica-
tions occurring in IDM. Maternal hyperglycemia leads to
fetal hyperglycemia which causes hyperinsulinism by 
stimulating the pancreatic islet cells in the fetus (10). The
hyperinsulinemic status results in intrauterine growth of fat
tissue, increased liver glycogen stores and  increased body
mass. These changes are expressed as increased somatic
growth, obesity and metabolic disturbances (11).  
Along with fetal hyperinsulinemia, macrosomia and 
hypoglycemia, maternal hyperglycemia can also cause 
asymmetric septal hypertrophy in the infant. Hyperinsulinemia
induces increased synthesis of protein, glycogen and fat leads
to hyperplasia and hypertrophy of the myocardium (12).
Atherosclerosis is a chronic progressive process, 
starting from the arterial wall and proceeding to the 
obstruction of the lumen. Clinical signs and symptoms occur
only in the advanced stages (13). Increased IMT of blood 
vessels in peripheral arteries can be assessed with 
B-mode ultrasonography in the early stages of atherosclerosis.
Pignoli et al (7)  have demonstrated the compatibility of 
ultrasonographic and histologic measurements of healthy
and atherosclerotic carotid arteries . Akcakus et al (15) and
Koklu et al (14,15) found significantly higher aortic IMT 
values in macrosomic newborns and  considered this 
finding  to be associated with  the atherosclerotic process
(16). Today CA- IMT is accepted as an important parameter
to be used in the assessment of patients who are at high risk
for atherosclerosis. Atabek et al (17) reported increased 
CA-IMT in diabetic children and adolescents. In these 
studies, the carotid artery was chosen for assessment since it
is easily visualized by ultrasonography. However, 
atherosclerotic lesions usually start in the abdominal aorta. In
our study, we found no differences in IMT values between
IDM and control cases. The finding of non-increased IMT
might be due to the fact that we used as parameter CA- IMT,
which may not have been affected yet. Measuring carotid artery
in neonates  without a linear probe and measuring a small area
of the region constituted the difficulty of this study. The small
number of subjects in our sample and the above-mentioned
methodological problem were the main limitations of our study. 
Serum lipid, insulin, C-peptide and leptin levels were all
reported to be elevated in IDM (18). We found no correlation
between birth weight, height, head circumference, ponderal
index and CA- IMT.
Mehta et al (19) observed no differences between 
macrosomic and non-macrosomic IDM by echocardiography,
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Table 1. Clinical characteristics and laboratory findings of the neonates
AGA IDM LGA  IDM  Controls p
Birth weight (g) 3150±326 4248±231 3129±393 0.0001
Length (cm) 50.1±1.4 51.8±0.8 49.7±1.0 0.0001
Head circumference (cm) 35.2±0.8 35.9±0.7 35.2±1.1 0.007
Ponderal index 2.5±0.1 3.0±0.1 2.5±0.2 0.0001
Triglyceride (mg/dL) 125.1±136.5 111.0±121.4 75.2±70.8 0.495
Total cholesterol (mg/dL) 112.5±65.2 129.6± 67.6 53.5±10. 0.714
LDL (mg/dL) 51.5±29.0 61.0±40.3 55.4±32.0 0.882
HDL (mg/dL) 33.0±19.8 37.3±24.0 34.4±17.6 0.939
Glucose (mgdL) 60.1±15.0 69.8±32.7 66.0±18.7 0.625
Insulin (mU/mL) 13.4±18.0 35.8±75.8 4.1±3.1 0.032
C-peptide (μ/L) 2.3±1.6 3.2±3.8 1.7±0.8 0.602
LVMI 52.56±40.97 54.0±20.72 40.97±13.38 0.035
IMT 0.031±0.002 0.032±0.003 0.030±0.004 0.217
IDM: infants of diabetic mothers, LVMI: left ventricular mass index, IMT: intima-media thickness, AGA: appropriate for gestational age, LGA: large for gestational age, 
LDL: low-density lipoprotein, HDL: high-density lipoproteinwhile Demiroren et al (20) reported that LVMI was the most
important echocardiographic measurement for distinguishing
macrosomic infants of diabetic and non-diabetic mothers.
Akcakus et al (15) found an increased LVMI in macrosomic
IDM. In our study, LVMI values were elevated in LGA IDM.
Our results demonstrate that macrosomia and  hypertrophic
cardiomyopathy in IDM are  associated findings.
Increased levels of glucose, insulin, C-peptide and HbA1c in
the cord blood of IDM  have been shown to be predictive 
for the  clinical course of the infant as well as susceptibility to 
atherosclerosis (21,22,23). In our study, in accordance with 
previous reports, cord insulin levels were significantly high in
IDM. On the other hand, cord C-peptide and glucose levels
showed no differences compared to the values in the controls.
147
Atabek ME et al.
Intima-Media Thickness in Infants of Diabetic Mothers
Table 2. Correlations between anthropometric measurements, cardiovascular risk factors and CA-IMT
AGA IDM (n=14) LGA IDM (n=16)                                           Controls (n=25)
rpr p rp
Birth weight (g) 0.560 0.037 -0.223 0.407 0.053 0.802
Height (cm) 0.394 0.163 -0.259 0.333 0.123 0.558
Head circumference (cm) 0.626 0.017 0.029 0.914 -0.206 0.324
Ponderal index 0.437 0.118 -0.069 0.798 -0.045 0.830
Triglyceride (mg/dL) -0.169 0.564 -0.158 0.558 -0.341 0.095
Total cholesterol (mg/dL) -0.088 0.764 -0.172 0.525 0.131 0.541
LDL (mg/dL) -0.284 0.324 -0.252 0.430 -0.057 0.790
HDL (mg/dL) -0.228 0.434 -0.266 0.402 -0.224 0.442
Glucose (mg/dL) 0.206 0.480 -0.194 0.471 0.077 0.719
Insulin (mU/mL) -0.166 0.570 -0.097 0.720 0.192 0.357
C-peptide (μ/L) -0.277 0.338 -0.062 0.821 -0.154 0.472
LVMI 0.009 0.977 -0.368 0.161 -0.297 0.150
CA-IMT: carotid artery intima-media thickness, LVMI: left ventricular mass index, AGA: appropriate for gestational age, LGA: large for gestational age, LDL: low-density lipoprotein,
HDL: high-density lipoprotein, IDM: infants of diabetic mothers 
Table 3. Correlations between anthropometric measurements, cardiovascular risk factors and LVMI
AGA IDM (n=14) LGA IDM (n=16) Controls (n=25)
rpr p rp
Birth weight (g) 0.177 0.540 -0.122 0.638 0.111 0.593
Height (cm) 0.351 0.218 0.051 0.852 -0.104 0.619
Head circumference (cm) -0.491 0.750 0.114 0.674 0.220 0.291
Ponderal index -0.111 0.706 -0.107 0.692 0.220 0.291
Triglyceride (mg/dL) -0.288 0.317 0.077 0.778 0.225 0.280
Total cholesterol (mg/dL) -0.334 0.243 0.025 0.927 0.270 0.191
LDL (mg/dL) -0.350 0.220 0.112 0.705 0.147 0.496
HDL (mg/dL) -0.254 0.381 0.178 0.581 -0.152 0.478
Glucose (mg/dL) -0.423 0.132 -0.61 0.824 -0.044 0.839
Insulin (mU/mL) 0.023 0.936 0.384 0.142 -0.082 0,696
C-peptide (μ/L) 0.252 0.385 0.248 0.354 0.115 0.596
IMT 0.009 0.977 -0.348 0.186 -0.297 0.150
IMT: intima-media thickness, LVMI: left ventricular mass index, AGA: appropriate for gestational age, LGA: large for gestational age, LDL: low-density lipoprotein, HDL: high-density
lipoprotein, IDM: infants of diabetic mothers These results indicate that hyperinsulinism is the most 
effective parameter for macrosomia.
Serum lipid levels were found high in IDM in our study, a
finding reported in many studies (14,16,24,25). 
A correlation between lipid profile and IMT has been shown
in obese children in several studies (26,27). However, in this
sample, we found no association between lipid profiles and 
CA- IMT.
In conclusion, in the present study, increased LVMI values
were found in IDM as compared to control cases, while no 
significant differences in CA-IMT were observed among the
groups. From these results, we infer that macrosomic IDM
may be prone to hypertrophic cardiomyopathy but not to 
atherosclerotic changes in the blood vessels. 
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